Tag: cardiology

24Jul

NIMBLE I
NIMBLE-I  We are excited to share that NIMBLE-I, our first-in-human clinical study, is now officially completed.   Fifty-six patients were enrolled at the Hospital Universitari Germans Trias i Pujol (Can Ruti) in Badalona, Spain, marking an important milestone in the journey of the WAEVE® System from laboratory prototype to clinical reality.  The Problem  Every year, hundreds of thousands of patients undergo coronary stent implantation to treat blocked arteries. While stents are life-saving, living with one is not without uncertainty. In-stent restenosis (ISR), the re-narrowing of the artery inside the stent, affects between 5% and 10% of all patients with a stent. Aside restenosis, stent fractures and other structural complications add …

From your kitchen to Clinical Settings
Microwaves don't just heat food: they detect tumors, guide cancer therapies, and monitor stents with zero radiation. Discover how this technology is reshaping modern medicine. The solution: Waeve system.

Welcoming Prof. Dr. Morton J. Kern to our Team
NIMBLE is delighted to announce that Prof. Dr. Morton J. Kern, MD, a leading clinician in interventional cardiology, has joined our Medical Advisory Board. His expertise will play a pivotal role in guiding our clinical strategy, particularly as we prepare for entry into the US market and pursue FDA approval.   Background: Dr. Kern is a Professor of Medicine at the University of California, Irvine in the Division of Cardiology. He is also Chief of Cardiology at the Long Beach Veterans Administration Medical Center. Dr Kern received his medical degree …

Diagnosis of Coronary Ischemia – When to Consider an Angiography?
Can angiography be avoided? Alternative Diagnostic Methods Angiography has become one of the most important medical discoveries due to its ability to diagnose and investigate numerous problems affecting blood vessels, including coronary artery disease. Since this is the only method currently used to determine if a stent is needed or if a pre-placed stent is in restenosis, alternative diagnostic methods are being looked into to reduce risks and costs.  What is Angiography? Angiography is a diagnostic procedure that uses imaging to show how blood flows through blood vessels or the …

NIMBLE Diagnostics CTO Susana Amorós: Leader of Innovation
NIMBLE Diagnostics has a strong collection of leaders steering its development and innovation as its technology succeeds expectations. Their CTO, Susana Amorós, sat down to discuss what brought her to the project, the next steps, and the inspiration that brought her to change lives. Amorós began her studies at UPC studying telecommunications engineering. However, during her last year, she discovered her passion — working in the medical sector of her field. With her degree, she would be able to aid in the design, testing, and manufacturing of medical equipment. Understanding …
medical-alert-systems13Jun

NIMBLE Diagnostics: Non-invasive medical technology used to monitor patients with implanted coronary stents
Societal challenge: No method for proactively monitoring implanted stents NIMBLE Diagnostics’ novel technology will make waves in the medical community and in the treatment of cardiovascular disease. Atherosclerosis is the leading cause of most cardiovascular diseases, as it often forms blood clots and causes a restriction of oxygen-rich blood flow to the tissues. This blockage can cause various diseases, such as coronary artery disease, stroke, peripheral arterial disease, and aneurysms. Stents are small, metallic tubes implanted in the location of the obstruction to restore blood flow or other fluids. Initially, …
dayone-stent03Mar

NIMBLE Diagnostics: DayOne Innovation Summit
DayOne Innovation Summit 4FYN hosted by Fundacion la Caixa in Barcelona, Spain. At this conference, innovation and technology were celebrated in a gathering of ingenious companies aiming to change the world through technology and new ideas. Congratulations to Sycai Medical on their award, and we look forward to continuing to develop and change lives. …
nimble-diagnostics-cardiology-stent03Feb

Winner of Barcelona Activa Technology Grant
NIMBLE Diagnostics had recognition once more for its innovation and groundbreaking technology. This past week NIMBLE participated in and won first place in an accelerator program organized by Barcelona Activa and Grow Venture Partners. This program was created for early-stage technology projects, disruptive technologies, and technology in the validation stage in laboratory environments. NIMBLE competed against 7 selected projects and was judged by a panel of 4 experts, pushing the revolutionary technology to the final round where NIMBLE was judged by a panel of 19 professionals. After careful deliberation, NIMBLE was chosen for …
igtp-medicine-cardiac-stent15Ene

NIMBLE Diagnostics Closed Funding of Over 1 million Euros
Awarded 1.000.000 Euros NIMBLE Diagnostics’ funding has shown immense success. NIMBLE Diagnostics has successfully closed a funding round led by Grow Venture Partners together with Namarel Ventures and Inveniam Group. They have secured over 1 million euros to continue their mission of saving lives through preventative care. NIMBLE Diagnostics is a spin-off company of experts in the cardiology field of Germans Trias i Pujol Research Institute (IGTP), the Universitat Politècnica de Catalunya (UPC) – BarcelonaTech and the Universitat de Barcelona. They are all working together to create a medical technology device, the first of …

NIMBLE Diagnostics provides peace of mind to patients and clinicians by developing innovative medical devices. The device is currently in the regulatory submission phase.

  • IGTP Institut Germans Tries i Pujol
     Camí de les Escoles, s/n
    08916 Badalona, Barcelona
Explore
Contact us